Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G J Smits

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Current Opinion in Microbiology|August 25, 1999
Cell wall dynamics in yeastG J Smits, J C Kapteyn, H van den Ende, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 8, 1998
Cardioprotective effects of the novel adenosine A1/A2 receptor agonist AMP 579 in a porcine model of myocardial infarctionG J Smits, M McVey, B F Cox, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1991
Hemodynamic basis for the depressor activity of zaprinast, a selective cyclic GMP phosphodiesterase inhibitorA J Trapani, G J Smits, D E McGraw, et al.
Yeast (Chichester, England)|April 1, 1996
High-affinity glucose uptake in Saccharomyces cerevisiae is not dependent on the presence of glucose-phosphorylating enzymesH P Smits, G J Smits, P W Postma, et al.
FEMS Microbiology Letters|May 7, 1998
Transcription of multiple cell wall protein-encoding genes in Saccharomyces cerevisiae is differentially regulated during the cell cycleL H Caro, G J Smits, P van Egmond, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 21, 2001
A(1) receptor blockade induces natriuresis with a favorable renal hemodynamic profile in SHHF/Mcc-fa(cp) rats chronically treated with salt and furosemideE K Jackson, C K Kost, W A Herzer, et al.
Journal of Cardiovascular Pharmacology|May 5, 1999
Cardiovascular pharmacology of the adenosine A1/A2-receptor agonist AMP 579: coronary hemodynamic and cardioprotective effects in the canine myocardiumM J McVey, G J Smits, B F Cox, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1993
In vitro and in vivo characterization of an A1-selective adenosine agonist, RG14202L A Merkel, L M Rivera, D J Colussi, et al.
American Journal of Hypertension|July 1, 1993
In vivo pharmacology of SC-51316, a nonpeptidic angiotensin II receptor antagonistG M Olins, G J Smits, J P Koepke, et al.
Pharmacology|October 1, 1995
Cardiovascular and antilipolytic effects of the adenosine agonist GR79236L A Merkel, E D Hawkins, D J Colussi, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Current Opinion in Microbiology|August 25, 1999
Cell wall dynamics in yeastG J Smits, J C Kapteyn, H van den Ende, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 8, 1998
Cardioprotective effects of the novel adenosine A1/A2 receptor agonist AMP 579 in a porcine model of myocardial infarctionG J Smits, M McVey, B F Cox, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1991
Hemodynamic basis for the depressor activity of zaprinast, a selective cyclic GMP phosphodiesterase inhibitorA J Trapani, G J Smits, D E McGraw, et al.
Yeast (Chichester, England)|April 1, 1996
High-affinity glucose uptake in Saccharomyces cerevisiae is not dependent on the presence of glucose-phosphorylating enzymesH P Smits, G J Smits, P W Postma, et al.
FEMS Microbiology Letters|May 7, 1998
Transcription of multiple cell wall protein-encoding genes in Saccharomyces cerevisiae is differentially regulated during the cell cycleL H Caro, G J Smits, P van Egmond, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 21, 2001
A(1) receptor blockade induces natriuresis with a favorable renal hemodynamic profile in SHHF/Mcc-fa(cp) rats chronically treated with salt and furosemideE K Jackson, C K Kost, W A Herzer, et al.
Journal of Cardiovascular Pharmacology|May 5, 1999
Cardiovascular pharmacology of the adenosine A1/A2-receptor agonist AMP 579: coronary hemodynamic and cardioprotective effects in the canine myocardiumM J McVey, G J Smits, B F Cox, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1993
In vitro and in vivo characterization of an A1-selective adenosine agonist, RG14202L A Merkel, L M Rivera, D J Colussi, et al.
American Journal of Hypertension|July 1, 1993
In vivo pharmacology of SC-51316, a nonpeptidic angiotensin II receptor antagonistG M Olins, G J Smits, J P Koepke, et al.
Pharmacology|October 1, 1995
Cardiovascular and antilipolytic effects of the adenosine agonist GR79236L A Merkel, E D Hawkins, D J Colussi, et al.
Pageof 4